[Increased fibrinolytic activity in thrombocytopenia and its therapeutic modification by PAMBA].
D062365:Aminobenzoates / Q000627:therapeutic use*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D000991:Antithrombins / Q000096:biosynthesis / Q000502:physiology; D001778:Blood Coagulation Disorders / Q000209:etiology; D001780:Blood Coagulation Tests; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D013300:Streptokinase; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000503:physiopathology
D062365:Aminobenzoates; D000933:Antifibrinolytic Agents; D000991:Antithrombins; D005340:Fibrinogen; D013300:Streptokinase
Erhöhte fibrinolytische Aktivität bei Thrombozytopenie und ihre therapeutische Beeinflussung durch PAMBA.